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Abstract
Background: DDX5/p68 RNA helicase is a member of the DEAD (Asp-Glu-Ala-Asp) box proteins. Apart from RNA
unwinding, DDX5 is an important transcriptional factor and co-activator in cell proliferation and differentiation.
Findings: Here, we have characterised the role of DDX5 in adipogenesis in 3T3-L1 cells using siRNA mediated
suppression. Transient inhibition of Ddx5 mRNA expression at the start of adipogenesis impairs the differentiation
programme even when DDX5 expression is restored later in adipogenesis. However transient suppression of Ddx5
at the later stages of adipogenesis do not impair adipogenesis or triglyceride accumulation suggesting Ddx5
expression is dispensable in a mature adipocyte.
Conclusion: These results implicate DDX5 as a crucial factor involved in the complex transcriptional cascade of
events that regulate adipogenesis and essential to the initiation of adipogenesis.
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Introduction
DEAD (Asp-Glu-Ala-Asp) Box Protein 5 (DDX5), or
p68 RNA helicase is a multifunctional nuclear factor,
first identified by its immunological cross-reactivity to a
monoclonal antibody to the large T antigen of simian
virus 40 [1]. DDX5 is a prototypical member of the
DEAD/H-box protein family. The DEAD box family is
characterized by a region of nine conserved amino acid
motifs including Asp-Glu-Ala-Asp (DEAD) which are
required in cellular functions such as pre-mRNA pro-
cessing and ribosome biogenesis [2]. Co-purification of
DDX5 with spliceosomes suggested a role in RNA spli-
cing and this was subsequently confirmed when DDX5
was shown to be an essential splicing protein acting at
the U1 snRNA-5′ splice site [3]. More recently, DDX5
has been reported to co-activate several transcription
factors in proliferation and differentiation that are them-
selves highly regulated, including the estrogen receptor
α (ERα), tumour suppressor p53, androgen receptor
(AR), myogenic regulator MyoD, and the osteoblast
differentiation factor Runx2 [4]. DDX5 has been hinted
at to be involved in adipogenesis in one report [5], al-
though with rudimentary characterisation. Here we
sought to clarify the requirement of DDX5 in adipogene-
sis using a transient knockdown strategy.
Materials and methods
Cell culture and adipogenesis
3T3-L1 murine preadipocytes and C3H10T1/2 murine
mesenchymal stem cells were cultured in high glucose
(4500 mg/L) Dulbecco’s modified Eagle medium (DMEM)
supplemented by 10 % heat-inactivated Newborn Calf
Serum (NCS) (Sigma-Aldrich N4637) as described [6].
Two days after reaching 100 % confluence, cells were
induced to differentiate into adipocytes in high glucose
DMEM supplemented with 10 % Fetal Calf Serum
(FCS) as described [6]. Oil Red O staining of lipid accu-
mulation was performed as described [6] and triglyceride
levels were quantified using a triglyceride quantification
kit (Abcam, ab65336) according to the manufacturer’s
protocol.
RNA isolation and quantitative real-time PCR (qRT-PCR)
RNA extraction and purification was done using the
RNeasy Mini Kit (Qiagen, #74106) together with DNase
digestion using the RNase-free DNase digestion kit
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(Qiagen, #79254) and was performed according to the
manufacturer’s instructions. Purified RNA was reverse
transcribed as previously described [7]. Reactions were
performed using either Fast Taqman® master mix with
Taqman® primers or probes (ABI Biosystems) or SYBR®
green master mix (ABI Biosystems) and primers
(Table 1). Expression of all the genes were normalized to
the housekeeping gene Cyclophilin A (CycloA).
Western blot analysis
Cell lysis and western blotting was performed as described
[7]. Antibodies used for western blotting were against
PPARγ (E8)(Santa Cruz, sc-7273, 1:1000), DDX5 (PAb204,
kind gift from Frances-Fuller Pace, University of Dundee,
1:500) and GAPDH (FL-335, sc-25778, 1:2000).
siRNA mediated suppression of gene expression
Cells were treated with 20 μm of either a control non-
targeting siRNA or SMARTpool: ON-TARGETplus (GE
Lifesciences) siRNA targeted against Ddx5, Pparg or
Cebpb (Table 2) using Lipofectamine RNAiMAX (Life
Technologies) as described [8].
Cell viability assay
Cells were treated with WST-1 reagent using the WST-1
Cell Viability Assay Kit (Cayman Chemicals, #10008883)
according to the manufacturer’s protocol. Briefly, preadi-
pocytes were seeded at a density of 104 cells/cm2 in a
96-well plate in triplicates. Cells were normalized to un-
treated cells. Bleomycin (Sigma-Aldrich, B8416) was
used as a negative control (cytotoxic agent) at 200 μg/ml.
Both siRNA treatment and bleomycin treatment were
administered for 48 h.
Results
DDX5 expression in differentiating adipocytes- We inves-
tigated the expression of DDX5 during adipogenesis in
two widely used preadipocytic lines, 3T3-L1 and
C3H10T1/2 mesenchymal stem cells. We differentiated
these lines for 8 days in vitro and assessed the mRNA
and protein expression of DDX5. We observed that the
mRNA expression of Ddx5 in 3T3-LI cells peaked at day
2 of differentiation (Fig. 1a) whereas Ddx5 was most
strongly expressed before adipogenic induction (D0) in
C3H10T1/2 cells (Fig. 1b). However, at the protein level,
DDX5 peaked at D2 of differentiation in both these
cell lines (Fig. 1c, d). The expression of peroxisome-
proliferator activated receptor γ (PPARγ), a critical regula-
tor of adipogenesis, that is induced during differentiation,
confirmed functional adipogenesis (Fig. 1c, d).
DDX5 is required for adipogenesis –Next, we investi-
gated the consequences of supressing Ddx5 expression
using siRNA. We obtained an >80 % reduction in tran-
script levels using siRNA targeted against Ddx5 in 3T3-
L1 cells but only a ~55 % reduction in C3H10T1/2 cells
compared to cells treated with control siRNA (Fig. 1e, f ).
Cell viability was assessed to investigate if the Ddx5
knockdown impaired viability. We observed that Ddx5
knockdown did not significantly impair viability (>90 %
viability) when compared to untreated cells (Fig. 1g).
Given the greater knockdown observed in 3T3-L1 cells,
subsequent knockdown experiments were performed on
3T3-L1 cells to understand how the loss of Ddx5 affects
adipogenesis. Ddx5 was suppressed throughout adipogen-
esis in a sustained and systematic manner by the addition
of siRNA every 2 days starting from 2 days before the
induction of adipogenesis to day 6 of differentiation
(Fig.2a, d). We found that treatment with siRNA
against Ddx5 resulted in impaired triglyceride accumu-
lation compared to treatment with control siRNA, as
observed by brightfield microscopy, Oil Red O staining
and triglyceride quantification (Fig. 2b, c). Cells were also
treated with siRNA against Pparg as a positive control, as
it is well established that disruption of Pparg expression
blocks triglyceride accumulation and adipogenesis [9].
Since Ddx5 suppression impairs triglyceride accumulation,
Table 1 SYBR green primers used for quantitative real-time PCR





Table 2 The SMARTpool siRNA ON-TARGETplus mouse siRNA
(Thermo Scientific) designed to specifically target mouse Ddx5,
Pparg and Cebpb. The SMARTpool siRNA consists of four individual
duplexes designed to obtain a high level of gene silencing.
The non-targeting siRNA is a negative control siRNA with at least
four mismatches to any human mouse or rat gene
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we determined if this was due to impaired adipogenesis.
We assessed mRNA expression of Ddx5, CCAAT enhan-
cer binding protein β (Cebpb), a transcription factor crit-
ical at the early stages of adipogenesis [9], Pparg, a critical
regulator that maintains the mature adipocytic state [9],
and Lmna whose expression is relatively stable during adi-
pogenesis and in fully differentiated cells [10]. Ddx5 ex-
pression was significantly suppressed by siRNA treatment
throughout adipogenesis as expected (Fig. 2d). Both Cebpb
and Pparg expression were also significantly reduced
Ddx5 mRNA expression (3T3-L1) Ddx5 mRNA expression (C3H10T1/2)
A) B)







3T3-L1 cells C3H10T1/2 cells
3T3-LI siRNA knockdownE) C3H10T1/2 siRNA knockdownF) WST-1 Assay (Cell Viability)G)
D)
Fig. 1 mRNA and protein expression of DDX5 assayed in 3T3-L1 preadipocytes and C3H10T1/2 mesenchymal stem cells induced to undergo
adipogenesis for 8 days in vitro. mRNA expression of Ddx5 in (a) 3T3-L1 and (b) C3H10T1/2 cells differentiated for 8 days in vitro. Black bars
indicate the peak of mRNA expression. Protein expression by western blotting for DDX5, PPARγ and GAPDH in (c) 3T3-L1 and (d) C3H10T1/2
cells differentiated for 8 days in vitro. Western blot bands were quantified using ImageJ. Transient knockdown using siRNA were performed on
(e) 3T3-L1 and (f) C3H10T1/2 cells. g Cell viability assay using WST-1 was performed using cells treated with control siRNA (siControl), siRNA
against Ddx5 (siDDX5) and bleomycin and compared to untreated cells. Data are represented as % cell viability compared to untreated cells.
*p < 0.05, **p < 0.01, ***p < 0.001. Experiments were done in triplicates and error bars indicate SEM (n = 3). mRNA expression data and western
blot densitometry were normalized to CycloA and GAPDH expression respectively
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(Fig. 2e, f ), suggesting that both these early and later regu-
lators of adipogenesis are reduced by the knockdown of
Ddx5. Lmna expression was unaffected by the Ddx5 in-
hibition (Fig. 2g) suggesting that the Ddx5 suppression
particularly affects genes that regulate adipogenesis.
DDX5 is crucial at the early stages of adipogenesis –
Given the peak of expression at D2 of differentiation
(Fig. 1a, c) and since Ddx5 is required for adipogenesis
(Fig. 1e, f ), we investigated the possibility of Ddx5 being
crucial to the early stages of adipogenesis. We investigated
Ddx5 mRNA expression
A)
D0 D2 D4D(-2) D6 D8












Fig. 2 Sustained knockdown of Ddx5 in 3T3-L1 cells differentiated for 8 days in vitro. (a) Cells were treated with siRNA continuously up to day 6
of differentiation and (b) viewed under a microscope and also stained for lipid accumulation using Oil Red O Stain. (c) Triglyceride accumulation
was quantified and mRNA expression of (d) Ddx5, (e) Cebpb, (f) Pparg and (g) Lmna were investigated. All experiments were done in triplicates
and statistical significance are denoted as follows: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars indicate SEM (n = 3). mRNA expression data were nor-
malized to CycloA expression respectively
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this by transiently suppressing Ddx5 mRNA expression at
the initial stages of adipogenesis: 2 days before adipogenic
induction of adipogenesis (D-2) and at the same time as
adipogenic induction (D0) (Fig. 3a, b). Differentiation was
maintained for 8 days, however triglyceride accumulation
was severely impaired, indicating defective adipogenesis
(Fig. 3b, c). Cebpb is a well-established crucial factor in
the early stages of adipogenesis [9], and was analyzed to
further understand how the loss of Ddx5 affects early adi-
pogenesis. While Ddx5 was only transiently suppressed at
the early stages of differentiation (Fig. 3d), the expression
of both Cebpb and more interestingly Pparg, a gene
expressed much later in adipogenesis, were impaired com-






Cebpb mRNA expressionDdx5 mRNA expression
Pparg mRNA expression Lmna mRNA expression
TG quantification
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Fig. 3 Early knockdown of Ddx5 in 3T3-L1 cells differentiated for 8 days in vitro. (a) Cells were treated with siRNA only at D(−2) and D0 of differentiation
and (b) viewed microscopically and also stained for lipid accumulation using Oil Red O stain. (c) Triglyceride accumulation was quantified and mRNA
expression of (d) Ddx5, (e) Cebpb, (f) Pparg and (g) Lmna were investigated. All experiments were performed in triplicates and statistical significance are
denoted as follows: *p< 0.05, **p < 0.01, ***p< 0.001. Error bars indicate SEM (n= 3). mRNA expression data were normalized to CycloA
expression respectively
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whereas the expression of Lmna was unaffected (Fig. 3g).
Cebpb induces the expression of Pparg [9] and this may ex-
plain, at least in part, the suppression of Pparg expression.
DDX5 is not required in mature adipocytes – Since
Ddx5 was required during the early stages of adipogenesis
we investigated the requirement for DDX5 at the later
stages of adipogenesis. Differentiating 3T3-LI adipocytes
were treated with siRNA at days 4 and 6 of differentiation
(Fig. 4a). Prior to this, the cells are differentiated but un-
treated and so indistinguishable experimentally. Thus data
only from D4 onwards would be relevant and meaningful
and only these are presented. In addition, analysis of
Cebpb is also omitted given that its expression is only rele-
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Fig. 4 Late knockdown of Ddx5 in 3T3-L1 cells differentiated for 8 days in vitro. (a) Cells were treated with siRNA only at D4 and D6 of
differentiation and (b) viewed microscopically and also stained for lipid accumulation using Oil Red O stain. (c) Triglyceride accumulation
was quantified and mRNA expression of (d) Ddx5, (e) Pparg and (f) Lmna were described. All experiments were done in triplicates and statistical
significance are denoted as follows: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars indicate SEM (n = 3). mRNA expression data were normalized to CycloA
expression respectively
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targeting Ddx5 in this manner accumulated triglycerides
as well as cells treated with control siRNA (Fig. 4b, c).
However treatment with siRNA against Pparg impaired
the maintenance of the mature adipocyte state, consistent
with previous reports [11]. Ddx5 siRNA suppressed Ddx5
expression (Fig. 4d) but Pparg and Lmna levels were un-
affected (Fig. 4e, f ). Ddx5 therefore appears to be essential
for the initial stages of adipogenesis, but not at the later
stages of differentiation and maintenance of the mature
adipocyte state.
Discussion
Here we demonstrate that DDX5/p68 RNA helicase peaks
in expression on day 2 of adipogenesis in two different
murine cell lines (Fig. 1a–d). These observations led us to
speculate that this transient expression is required at the
early stage of adipogenesis. The transcriptional pathways
controlling adipocyte differentiation are relatively well
characterized [12]. Adipogenesis is regulated by a cascade
in the expression of a variety of transcription factors
where an early wave of factors is induced immediately at
the start of differentiation. These factors then activate a
second set of transcription factors that are responsible in
maintaining the mature and functional adipocyte. Utilising
a transient knockdown strategy, we observed that DDX5
is essential during the initial stages of adipogenesis (Fig. 3)
but not at later stages (Fig. 4). This suggests a role for
DDX5, potentially as a transcriptional co-activator, at the
early stages of adipocytic differentiation, placing it in the
same category as other well established transcriptional fac-
tors such as C/EBPβ/δ and the Kruppel-like factors (KLFs)
[9]. In future studies it will be of interest to examine how
the loss of Ddx5 affects lipid droplet biology given the in-
creasing evidence of genes expressing lipid droplet associ-
ated proteins being implicated in metabolic diseases such
as lipodystrophy [13]. This unappreciated role of DDX5 in
adipogenesis provides further insight into adipogenic
molecular pathways, providing an additional potential
target to address metabolic diseases including obesity
and type 2 diabetes that are of increasing importance
to global public health.
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